AD Ports Logistics and Acino sign a global pharma freight forwarding agreement

AD Ports Logistics (ADPL), a subsidiary of the logistics cluster, AD Ports Group, the world’s leading intermediary in trade, logistics and industry based in Abu Dhabi (ADPORTS:ADX), and Acino, a Swiss pharmaceutical company that develops and manufactures well – proven and innovative medicines, have signed a milestone agreement for ADPL to provide Acino with global freight forwarding services, including ocean and air transportation in the Middle East and North Africa (MENA) region.

Under the terms of the agreement, ADPL will leverage its fully integrated and GDP-certified end-to-end pharma cold chain capabilities to ship essential medicines from Acino’s global origin sites to markets in the MENA region. The pharmaceutical products require special transport and handling options, which are provided by the ADPL Healthcare & Lifesciences division. Under the terms of the agreement, the scope of forwarding services includes first-mile transportation, seaport and airport loading, customs clearance and last-mile logistics.

Farook Al Zeer, Chairman of AD Ports Group Logistics Cluster, said: “We are delighted to have been selected by our partners at Acino as a pharma logistics provider. The agreement represents a significant development opportunity for our Healthcare & Lifesciences business as it allows us to work with a leading global pharmaceutical manufacturer and demonstrate our capabilities as a global trade and logistics enabler. We look forward to building a strong and lasting relationship with Acino and strengthening our reputation as a partner to the international pharmaceutical industry looking to expand its regional market share and footprint.”

Andrew Bird, Acino’s interim CEO, said, “Our collaboration with AD Ports Group strengthens our commitment to the MENA region, expands reach and improves patient access to quality healthcare.”

Mario Ricard, Acino’s Chief Operations Officer, said, “We are excited to partner with AD Ports Group to improve the speed and efficiency of delivering essential medicines to the MENA region and beyond.” Together, we shape healthcare new and pave the way for an innovative and patient-centric industry landscape.”

As the two companies are co-owned, ADPL and Acino will leverage their collaboration within a shared network of ADQ portfolio companies, unlocking greater value and seamless integration to the benefit of their customers.

Since its inception in 2020, ADPL has partnered with leading international logistics companies to develop one of the most integrated pharmaceutical supply chains in the world, capable of moving products at storage temperatures from -80°C to +25°C. As a member of the HOPE Consortium, an Abu Dhabi-led public-private partnership formed to combat the impact of the Covid-19 pandemic, the company helped deliver over 260 million doses of Covid-19 vaccine safely to over 65 countries to distribute around the world Hub in KEZAD, Abu Dhabi.

ADPL currently acts as a one-stop shop for a range of healthcare business solutions including trucking; contract logistics; Transport; and distribution solutions – including regulatory and quality compliance, commercial support and market access.

Related Articles

Back to top button